← All trials
NCT05747794
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 22, 2023
- Primary completion
- Oct 31, 2026
- Completion date
- Jul 31, 2027
- First posted
- Feb 28, 2023
- Last posted
- Oct 10, 2023
- Enrollment
- 849
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Immutep S.A.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.